🟢 99/100

This product looks safe

  • Folic Acid: 666mg is 666.0× the Tolerable Upper Intake Level (1.0mg)
  • 73% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Folic Acid: 666mg is 666.0× the Tolerable Upper Intake Level (1.0mg)

Label Data

1 Tablet(s) Serving Size
90 Servings
Other Combinations Product Type
73% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin A
1050 mcg (117% DV)
Vitamin C
90 mg (100% DV)
10 mcg (50% DV)
✅ Within RDA (0.7× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.01mg UL 0.1mg
20.3 mg (135% DV)
✅ 1.4× RDA — within safe limits 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 20.3mg UL 1000mg
20 mcg (17% DV)
✅ Within RDA (0.2× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.02mg
1.2 mg (100% DV)
✅ Within RDA (1.0× RDA of 1.2 mg) 📚 76 studies (Tier A: 0, B: 33)
RDA 1.2mg This product: 1.2mg
1.7 mg (131% DV)
✅ 1.3× RDA — within safe limits 📚 12 studies (Tier A: 0, B: 1)
RDA 1.3mg This product: 1.7mg
16 mg (100% DV)
✅ 1.1× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 16mg UL 35mg
3 mg (176% DV)
✅ 2.3× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 3mg UL 100mg
666 mcg DFE (100% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 666.0× (UL: 1.0 mg) 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 666mg UL 1.0mg
18 mcg (750% DV)
📊 7.5× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.018mg
30 mcg (100% DV)
✅ Within RDA (1.0× RDA of 0.03 mg) 📚 26 studies (Tier A: 0, B: 11)
RDA 0.03mg This product: 0.03mg
5 mg (100% DV)
✅ Within RDA (1.0× RDA of 5 mg) 📚 1 studies — no high-quality reviews
RDA 5mg This product: 5mg
Calcium
210 mg (16% DV)
120 mg (29% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 120mg
15 mg (136% DV)
✅ 1.4× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 15mg UL 40mg
105 mcg (191% DV)
✅ 1.9× RDA — within safe limits 📚 172 studies (Tier A: 0, B: 67)
RDA 0.055mg This product: 0.105mg UL 0.4mg
2 mg (222% DV)
✅ 2.2× RDA — within safe limits 📚 36 studies (Tier A: 0, B: 11)
RDA 0.9mg This product: 2mg UL 10mg
2 mg (87% DV)
✅ Within RDA (0.9× RDA of 2.3 mg) 📚 8 studies — no high-quality reviews
RDA 2.3mg This product: 2mg UL 11mg
120 mcg (343% DV)
📊 3.4× RDA — above typical dose 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.12mg
Potassium
100 mg (2% DV)
600 mcg
📊 Market median: 10.0mg (35 products) 📚 5 studies (Tier A: 0, B: 2)
This product: 0.6mg

Other Ingredients

Cellulose Croscarmellose Sodium Silicon Dioxide Stearic Acid Magnesium Stearate Ethylcellulose Pharmaceutical Glaze

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (91% of products) Nutrient (57% of products)

Target Groups

Adult Male (18-50 Years) Gluten Free

Product Information

📋 Directions for Use

Directions: Adults, one tablet daily, with food.

⚠️ Warnings & Precautions

Keep out of the reach of children.

Do not use if inner seal is missing or broken.

Warning: Not intended for use by pregnant or nursing women. If you are taking any medications or have any medical conditions, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

🧪 Formulation Notes

Healthy prostate Healthy heart

Gluten Free

Additional Information

Store in dry, cool room.

Basic's

High quality basics

Product Details

DSLD Entry Date 2021-05-22
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 250178
Data Updated 2026-04-11

Research Evidence

31 Research Sources
53 Avg Quality Score
12 Meta Analysis
9 Systematic Review
5 Rct
2 Clinical Trial
1 Regulatory Source
1 Openfda Safety
B Pentasaccharides for the treatment of deep vein thrombosis
Meta Analysis The Cochrane database of systematic reviews 2017
B Quantitative comparison of the efficacy of clinical drug treatments for primary progressive multiple sclerosis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2023
B Dietary interventions for multiple sclerosis-related outcomes
Meta Analysis The Cochrane database of systematic reviews 2020
B Interventions for infantile seborrhoeic dermatitis (including cradle cap)
Meta Analysis The Cochrane database of systematic reviews 2019
B Effect of varicocelectomy on sperm deoxyribonucleic acid fragmentation rates in infertile men with clinical varicocele: a systematic review and meta-analysis
Meta Analysis Fertility and sterility 2021
B Effect of feeding biotin on milk production and hoof health in lactating dairy cows: a quantitative assessment
Meta Analysis Journal of dairy science 2011
B Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature
Systematic Review The Journal of clinical endocrinology and metabolism 2016
B Effect of biotin on milk performance of dairy cattle: a meta-analysis
Meta Analysis Journal of dairy science 2011
B PROVIT: Supplementary Probiotic Treatment and Vitamin B7 in Depression-A Randomized Controlled Trial
Rct Nutrients 2020
B High-dose biotin for multiple sclerosis: A systematic review and meta-analyses of randomized controlled trials
Meta Analysis Multiple sclerosis and related disorders 2021
View all evidence for Biotin →

Compare Similar Products

View all Biotin products →